Table 1.

Patient demographic and medical characteristics

CharacteristicsLow Dose (0–20 mSv)Moderate Dose (>20–50 mSv)High Dose (>50–100 mSv)Very High Dose (>100 mSv)P ValueTotal
Total participants70 (40.7)51 (29.7)28 (16.3)23 (13.4)172
Female31 (44.3)22 (43.1)11 (39.3)7 (30.4)0.6871 (41.3)
Black16 (22.9)22 (43.1)10 (35.7)12 (52.7)0.0760 (34.9)
Age at evaluation (yr)<0.001
 18–4027 (38.6)4 (7.8)1 (3.6)3 (13.0)35 (20.4)
 >40–5020 (28.6)14 (27.5)4 (14.3)3 (13.0)41 (23.8)
 >50–6015 (21.4)22 (43.1)20 (71.4)9 (39.1)66 (38.4)
 >608 (11.4)11 (21.6)3 (10.7)8 (34.8)30 (17.4)
Etiology of renal disease0.002
 Diabetes mellitus8 (11.4)20 (39.2)8 (28.6)13 (56.5)49 (28.5)
 Hypertension16 (22.9)14 (27.5)6 (21.4)7 (30.4)43 (25.0)
 GN29 (41.4)8 (15.7)7 (25.0)2 (9.7)46 (26.7)
 Other17 (24.3)9 (17.7)7 (25.0)1 (4.4)34 (19.8)
Dialysis status at time of evaluation0.26
 Pre-emptive40 (57.1)20 (39.2)10 (35.7)12 (52.2)82 (47.7)
 On hemodialysis26 (37.1)29 (56.9)16 (57.1)11 (47.8)82 (47.7)
 On peritoneal dialysis4 (5.7)2 (3.9)2 (7.1)0 (0)8 (4.7)
Transplant type<0.001
 Deceased donor27 (34.3)30 (58.8)18 (64.3)18 (78.3)90 (52.3)
 Living donor46 (65.7)21 (41.2)10 (35.7)5 (21.7)82 (47.7)
Charlson comorbidity index0.07
 2–349 (70.0)23 (45.1)16 (57.1)6 (26.1)94 (54.7)
 4–517 (24.3)17 (33.3)6 (21.4)11 (47.8)51 (29.7)
 6–84 (5.7)11 (21.6)6 (21.4)6 (26.1)27 (15.7)
ABO blood type0.08
 Group A31 (44.3)24 (47.1)11 (39.3)3 (13.0)69 (40.1)
 Group AB5 (7.1)0 (0)2 (7.1)0 (0)7 (4.1)
 Group B8 (11.4)7 (13.7)4 (14.3)7 (30.4)26 (15.1)
 Group O26 (37.1)20 (39.2)11 (39.3)13 (56.5)70 (40.7)
Peak panel reactive antibody (%)0.11
 028 (40.0)25 (49.0)12 (42.9)15 (65.2)80 (46.5)
 1–1922 (31.4)13 (25.5)8 (28.6)2 (8.7)45 (26.2)
 20–7915 (21.4)11 (21.6)3 (10.7)3 (13.0)32 (18.6)
 80–10026 (37.1)20 (39.2)11 (39.3)3 (13.0)15 (8.7)
Time from initial evaluation to time of transplant (mo)<0.001
 0–1241 (58.6)20 (39.2)1 (3.6)0 (0)62 (36.1)
 >12–2411 (15.7)9 (17.7)7 (25.0)0 (0)27 (15.7)
 >24–4811 (15.7)10 (19.6)7 (25.0)5 (21.7)33 (19.2)
 >487 (10.0)12 (23.5)13 (46.4)18 (78.3)50 (29.1)
  • Data are given as n (%).